Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Methylglucamine ascorbate (also known as meglumine ascorbate or ascorbate-meglumine) is a salt formed from the combination of vitamin C (ascorbic acid) and methylglucamine (meglumine). As a derivative of vitamin C, it acts primarily through antioxidant mechanisms—scavenging free radicals and protecting cells from oxidative damage. Vitamin C is essential for collagen synthesis, immune function support, iron absorption enhancement from plant sources, and wound healing. The addition of meglumine may improve solubility or stability for certain pharmaceutical applications. This compound has been explored in research settings but does not appear to be widely marketed under specific brand names[1][4][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on methylglucamine ascorbate.